ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 160 filers reported holding ACORDA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $198,000 | -52.5% | 12,683 | -40.1% | 0.03% | -31.6% |
| Q2 2017 | $417,000 | +52.2% | 21,172 | +61.1% | 0.04% | +26.7% |
| Q3 2016 | $274,000 | -75.0% | 13,143 | -68.3% | 0.03% | -80.1% |
| Q1 2016 | $1,097,000 | +374.9% | 41,462 | +498.0% | 0.15% | +67.8% |
| Q1 2015 | $231,000 | -51.0% | 6,933 | -50.3% | 0.09% | -63.9% |
| Q2 2014 | $471,000 | -25.0% | 13,960 | -35.0% | 0.25% | -0.4% |
| Q4 2013 | $628,000 | – | 21,492 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |